$CDLX·8-K

Cardlytics, Inc. · May 7, 4:03 PM ET

Compare

Cardlytics, Inc. 8-K

Research Summary

AI-generated summary

Updated

Cardlytics Reports Q1 2026 Results; Files 8-K

What Happened

  • Cardlytics, Inc. (NASDAQ: CDLX) filed a Form 8-K on May 7, 2026 to announce its financial results for the three months ended March 31, 2026. The company issued a press release with the results and provided information about a conference call to discuss the quarterly results and recent corporate highlights. The press release is furnished as Exhibit 99.1 to the 8-K.

Key Details

  • Filing date: May 7, 2026; reporting period: three months ended March 31, 2026.
  • Press release announcing the quarterly results is included as Exhibit 99.1 to the Form 8-K.
  • The 8-K included conference call details to review the results and recent corporate highlights.
  • The report includes a cover page in Inline XBRL and was signed by Chief Financial Officer David Evans (Principal Financial and Accounting Officer).

Why It Matters

  • This 8-K makes Cardlytics’ latest quarterly financial results and management commentary available to investors; those results can affect assessments of revenue, profitability, and near‑term outlook. Investors should read the furnished press release and consider listening to the conference call for management’s discussion and any forward-looking commentary. This filing does not disclose other corporate actions beyond the quarterly results and related call information.

Loading document...